RobertE.BristowMDMBA
Obstetrics & Gynecology • Orange, CAGeneral Gynecology, Gynecologic Oncology
Professor and Chair Department of Obstetrics and Gynecology / University of California, Irvine
Dr. Bristow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
333 City Blvd West
Suite 1400
Orange, CA 92868Phone+1 714-456-8785- Is this information wrong?
Education & Training
Johns Hopkins UniversityMBA, Business Administration, 2003 - 2008
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gynecologic Oncology, 1995 - 1998
Johns Hopkins UniversityResidency, Obstetrics and Gynecology, 1991 - 1995
Keck School of Medicine of the University of Southern CaliforniaClass of 1991
Certifications & Licensure
CA State Medical License 1995 - 2025
MD State Medical License 1998 - 2010- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:San Diego Area Castle Connolly, 2013
- Join now to see all
Clinical Trials
- Paclitaxel in Treating Patients With Ovarian Stromal Cancer Start of enrollment: 2000 Nov 20
- Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer Start of enrollment: 2005 Mar 21
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Join now to see all
Publications & Presentations
PubMed
- Medicolegal, infrastructural, and financial aspects in gynecologic cancer surgery and their implications in decision making processes: Quo Vadis?Emma Allanson, Anjali Hari, Edgard Ndaboine, Paul A Cohen, Robert Bristow> ;International Journal of Gynecological Cancer. 2024 Mar 4
- Short-term survival analysis of a risk-adjusted model for ovarian cancer care.Chang, J., Villanueva, C., Ziogas, A., Vieira, V., Hari, A., Bristow, R.> ;Gynecologic Oncology. 2024 Feb 2
- 194 citationsSurvival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis.Robert E Bristow, Rafael S Tomacruz, Deborah K Armstrong, Edward L Trimble, F J Montz> ;Journal of Clinical Oncology. 2023 Sep 1
- Join now to see all
Other
- Neoadjuvant chemotherapy for newly diagnosed advanced ovarian cancerBristow RE, Konstantinopoulos PA
http://www.uptodate.com/contents/neoadjuvant-chemotherapy-for-newly-diagnosed-advanced-ovarian-cance
UpToDate, Wolters Kluwer Health - 2012-12-13
Press Mentions
Widespread Flaws Found in Ovarian Cancer TreatmentFebruary 12th, 2016
Professional Memberships
- Fellow
- Member
Hospital Affiliations
Providence St. Joseph Hospital OrangeOrange, California
UCI HealthOrange, California
Long Beach Medical CenterLong Beach, California- MemorialCare, Orange Coast Memorial Medical CenterFountain Valley, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
